Terms: = Liver cancer AND LMNA, EMD2, 4000, ENSG00000160789, LGMD1B, LDP1, PRO1, LMNC, FPLD, CDDC, HGPS, P02545, LFP, IDC, CMD1A, CDCD1, LMN1, CMT2B1, FPL AND Prognosis
37 results:
1. TH-4000, a hypoxia-activated pan-HER inhibitor, shows excellent preclinical efficacy for the treatment of HER2
Shao X; Yang D; Shan L; Yan X; Xu D; Li L; Sun Y; Yu Q; Zhou H; Ding Y; Tang J
Arch Toxicol; 2024 Mar; 98(3):865-881. PubMed ID: 38212449
[TBL] [Abstract] [Full Text] [Related]
2. Clinical characteristics and prognosis of primary small cell carcinoma of the breast: a propensity score-matched, population-based study.
Yin L; Yin AH; Pu CC
BMJ Open; 2023 Dec; 13(12):e073841. PubMed ID: 38097248
[TBL] [Abstract] [Full Text] [Related]
3. Histologic heterogeneity predicts patient prognosis of HER2-positive metastatic breast cancer: A retrospective study based on SEER database.
Wang Y; Liang Y; Ye F; Luo D; Jin Y; Li Y; Zhao W; Chen B; Wang L; Yang Q
Cancer Med; 2023 Sep; 12(18):18597-18610. PubMed ID: 37605516
[TBL] [Abstract] [Full Text] [Related]
4. Histopathological growth patterns of neuroendocrine tumor liver metastases.
Meyer Y; Bohlok A; Olthof P; Donckier V; Doukas M; Lucidi V; Vermeulen P; Grünhagen D; Verhoef C
Clin Exp Metastasis; 2023 Jun; 40(3):227-234. PubMed ID: 37183203
[TBL] [Abstract] [Full Text] [Related]
5. Molecular differences of angiogenic versus vessel co-opting colorectal cancer liver metastases at single-cell resolution.
Fleischer JR; Schmitt AM; Haas G; Xu X; Zeisberg EM; Bohnenberger H; Küffer S; Teuwen LA; Karras PJ; Beißbarth T; Bleckmann A; Planque M; Fendt SM; Vermeulen P; Ghadimi M; Kalucka J; De Oliveira T; Conradi LC
Mol Cancer; 2023 Jan; 22(1):17. PubMed ID: 36691028
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic impact of
Park HL; Lee SW; Hong JH; Lee J; Lee A; Kwon SJ; Park SY; Yoo IR
Cancer Imaging; 2023 Jan; 23(1):2. PubMed ID: 36600314
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic Significance of the Histopathological Growth Pattern and Tumor-Infiltrating Lymphocytes in Stratifying Survival After Hepatectomy for Colorectal liver Metastases.
Kanno H; Hisaka T; Fujiyoshi K; Akiba J; Hashimoto K; Fujita F; Akagi Y
Ann Surg Oncol; 2023 May; 30(5):3139-3147. PubMed ID: 36520232
[TBL] [Abstract] [Full Text] [Related]
8. A Lamin Family-Based Signature Predicts prognosis and Immunotherapy Response in Hepatocellular Carcinoma.
Yang Y; Xiao W; Liu R; Gao L; Chen J; Kan H
J Immunol Res; 2022; 2022():4983532. PubMed ID: 36405011
[TBL] [Abstract] [Full Text] [Related]
9. Tumor biology reflected by histological growth pattern is more important than surgical margin for the prognosis of patients undergoing resection of colorectal liver metastases.
Bohlok A; Inchiostro L; Lucidi V; Vankerckhove S; Hendlisz A; Van Laethem JL; Craciun L; Demetter P; Larsimont D; Dirix L; Vermeulen P; Donckier V
Eur J Surg Oncol; 2023 Jan; 49(1):217-224. PubMed ID: 36031469
[TBL] [Abstract] [Full Text] [Related]
10. CT, MRI, and radiomics studies of liver metastasis histopathological growth patterns: an up-to-date review.
Li S; Li Z; Huang X; Zhang P; Deng J; Liu X; Xue C; Zhang W; Zhou J
Abdom Radiol (NY); 2022 Oct; 47(10):3494-3506. PubMed ID: 35895118
[TBL] [Abstract] [Full Text] [Related]
11. Biomarker profile of invasive lobular carcinoma: pleomorphic versus classic subtypes, clinicopathological characteristics and prognosis analyses.
Zhang Y; Luo X; Chen M; Yang L; Lei T; Pu T; Wei B; Bu H; Zhang Z
Breast Cancer Res Treat; 2022 Jul; 194(2):279-295. PubMed ID: 35666367
[TBL] [Abstract] [Full Text] [Related]
12. Histopathological growth patterns of resected non-colorectal, non-neuroendocrine liver metastases: a retrospective multicenter study.
Meyer Y; Bohlok A; Höppener D; Galjart B; Doukas M; Grünhagen DJ; Labar A; Lucidi V; Vermeulen PB; Verhoef C; Donckier V
Clin Exp Metastasis; 2022 Jun; 39(3):433-442. PubMed ID: 35124739
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic implications of adaptive immune features in MMR-proficient colorectal liver metastases classified by histopathological growth patterns.
Messaoudi N; Henault D; Stephen D; Cousineau I; Simoneau E; Rong Z; Létourneau R; Plasse M; Dagenais M; Roy A; Lapointe R; Vandenbroucke-Menu F; Kunda R; Ysebaert D; Soucy G; Stagg J; Vermeulen P; Turcotte S
Br J Cancer; 2022 May; 126(9):1329-1338. PubMed ID: 34980880
[TBL] [Abstract] [Full Text] [Related]
14. [Adherence to adjuvant with therapy imatinib in patients with gastrointestinal stromal tumor: a national multi-center cross-sectional study].
Zhang P; Zhang J; Zhang B; Yang WC; Hu JB; Sun XF; Zhai G; Qian HR; Li Y; Xu H; Feng F; Wu XY; Liu HL; Liu HJ; Qiu HB; Wu XJ; Zhou YB; Shen KT; Kou YW; Fu Y; Jie ZG; Zou XM; Cao H; Gao ZD; Tao KX
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Sep; 24(9):775-782. PubMed ID: 34530558
[No Abstract] [Full Text] [Related]
15. Preoperative systemic chemotherapy alters the histopathological growth patterns of colorectal liver metastases.
Nierop PM; Höppener DJ; Buisman FE; van der Stok EP; Galjart B; Balachandran VP; Jarnagin WR; Kingham TP; Shia J; Mauer M; Nordlinger B; Julié C; Groot Koerkamp B; Doukas M; Vermeulen PB; Grünhagen DJ; D'Angelica MI; Verhoef C
J Pathol Clin Res; 2022 Jan; 8(1):48-64. PubMed ID: 34480530
[TBL] [Abstract] [Full Text] [Related]
16. MARCKS on Tumor-Associated Macrophages is Correlated with Immune Infiltrates and Poor prognosis in Hepatocellular Carcinoma.
Ren X; Ju Y; Wang C; Wei R; Sun H; Zhang Q
Cancer Invest; 2021 Oct; 39(9):756-768. PubMed ID: 34279157
[TBL] [Abstract] [Full Text] [Related]
17. Risk factors, prognostic factors, and nomograms for bone metastasis in patients with newly diagnosed infiltrating duct carcinoma of the breast: a population-based study.
Huang Z; Hu C; Liu K; Yuan L; Li Y; Zhao C; Hu C
BMC Cancer; 2020 Nov; 20(1):1145. PubMed ID: 33238981
[TBL] [Abstract] [Full Text] [Related]
18. Histopathological growth patterns correlate with the immunoscore in colorectal cancer liver metastasis patients after hepatectomy.
Liang JY; Xi SY; Shao Q; Yuan YF; Li BK; Zheng Y; Wang DS; Wu XJ; Ding PR; Chen G; Li LR; Wang FH; Wang ZQ; Pan ZZ; Xu RH; Li YH
Cancer Immunol Immunother; 2020 Dec; 69(12):2623-2634. PubMed ID: 32601799
[TBL] [Abstract] [Full Text] [Related]
19. Replacement and desmoplastic histopathological growth patterns in cutaneous melanoma liver metastases: frequency, characteristics, and robust prognostic value.
Barnhill R; van Dam PJ; Vermeulen P; Champenois G; Nicolas A; Rawson RV; Wilmott JS; Thompson JF; Long GV; Cassoux N; Roman-Roman S; Busam KJ; Scolyer RA; Lazar AJ; Lugassy C
J Pathol Clin Res; 2020 Jul; 6(3):195-206. PubMed ID: 32304183
[TBL] [Abstract] [Full Text] [Related]
20. Histologic features and genomic alterations of primary colorectal adenocarcinoma predict growth patterns of liver metastasis.
Wu JB; Sarmiento AL; Fiset PO; Lazaris A; Metrakos P; Petrillo S; Gao ZH
World J Gastroenterol; 2019 Jul; 25(26):3408-3425. PubMed ID: 31341365
[TBL] [Abstract] [Full Text] [Related]
[Next]